News Notification

Harvard Infectious Diseases in Adults 2024

45 views Tags: CME Harvard Medical School

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases

Harvard Infectious Diseases in Adults 2024 program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians.

Education is practical and results-driven:

  • Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases 

  • Newer antimicrobials and treatment strategies for highly resistant infections

  • The latest on COVID-19, including long COVID

  • Prevention and treatment of infections in immunocompromised hosts

  • Update on antifungal diagnostics and therapy

  • State-of-the-art and multidisciplinary approaches to common infections

  • Clinical approaches to complex, rare, and “don’t-miss” infections

  • Infections in persons with substance use disorder

  • What’s new in HIV prevention and management

  • New, evolving, emerging, and re-emerging infectious disease

Highlights of the 2024 Program

Expanded Case-Based and Problem-Solving Education 

The 2024 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions of our national experts in live question-and-answer sessions following the lectures and the workshops. Our speakers and panelists include not only ID experts, but those from fields such as surgery, radiology, cardiology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care. Our twelve multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, native and prosthetic valve endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections.

Treating Highly Resistant Infections, including:

  • MRSA and VISA (vancomycin-intermediate Staph aureus)

  • Extended spectrum beta-lactamase (ESBL)-producing Gram-negative rods

  • Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms

  • Vancomycin-resistant enterococci (VRE)

  • Aspergillus and non-aspergillus mold infections

  • Candida auris

  • Nontuberculous mycobacteria (NTM)

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:

  • Respiratory viral infections, including COVID-19

  • New and updated vaccines

  • Infections in the expanding populations of immunocompromised hosts

  • Infections in persons with substance use disorder

  • Infections of travelers and foreign-born persons

  • Systemic fungal infections

  • Native and device-related orthopedic infections

  • Central nervous system (CNS) infections

  • Ear, nose and throat (ENT) and eye infections

  • Bronchiectasis and pneumonia

  • HIV and its infectious and noninfectious complications

  • PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection

  • Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs

  • Hepatitis B and C infections

  • Tick- and mosquito-borne infections

  • Clostridioides difficile infection

  • Complicated urinary tract infections

  • Intra-abdominal infections

Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:

  • Rare and emerging infectious diseases, including Rift Valley Fever

  • Re-emergence of vaccine-preventable diseases, including poliomyelitis

  • Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus

  • Global infectious diseases of clinical importance

Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

  • Selecting the best antimicrobial and duration of treatment

  • Rapid detection and empiric treatment of life-threatening infectious diseases

  • Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials 

  • Optimizing empiric antimicrobial therapy: what to start, and when to narrow or stop  

Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:

  • Antimicrobial stewardship to prevent resistance and reduce cost

  • Infection control

  • Early inpatient ID consultations to improve outcomes

  • Strategies for management of infection in persons who inject drugs (PWID)


0 0 votes
Article Rating


1. Introduction and Road Map: Infectious Diseases of Adults – Dr. Nesli Basgoz

2. Principles of Antimicrobial Therapy – Dr. Alyssa R. Letourneau

3. Update on Antifungal Diagnostics and Therapy – Dr. Michael K. Mansour

4. Antimicrobial Stewardship – Dr. Alyssa R. Letourneau

5. An Antibiotic Allergy Toolkit – Dr. Kimberly Blumenthal

6. Infection Control 101 for the ID Clinician – Dr. Erica Shenoy

7. Panel Workshop #1: Resistant Gram-Positive Infections – I – Moderator: Dr. Alyssa R. Letourneau

8. Panel Workshop #2: Resistant Gram-Positive Infections – II – Moderator: Dr. Alyssa R. Letourneau

9. Panel Workshop #3: Resistant Gram-Negative Infections – I – Moderator: Dr. Alyssa R. Letourneau

10. Panel Workshop #4: Resistant Gram-Negative Infections – II – Moderator: Dr. Alyssa R. Letourneau

11. Clostridioides difficile Infection, including Recurrent and Refractory Disease and Novel Approaches – Dr. Elizabeth Hohmann

12. Plenary – Climate Change and Infectious Diseases – Dr. Regina LaRocque

1. Encephalitis and Healthcare-Associated CNS Infections: The Newest Guidelines and Best Practices – Dr. Allan R. Tunkel

2. Tick Talk: Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections – Dr. Kimon C. Zachary

3. Bone and Joint Infections: A Conceptual Framework – Dr. Sandra B. Nelson

4. Staphylococcus aureus: Déjà Vu All Over Again – Dr. Henry F. Chambers

5. Panel Workshop #5: Native Bone Infections, including Diabetic Foot Infection and Sacral Osteomyelitis – Moderator: Dr. Sandra B. Nelson

6. Panel Workshop #6: Orthopedic Device Infections: Prosthetic Joint Infections – Moderator: Dr. Sandra B. Nelson

7. State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections, including Mpox – Dr. Kevin L. Ard

8. New and Emerging Viruses – Dr. Martin S. Hirsch

9. Infectious Issues with Skin and Soft Tissues – Dr. Sandra B. Nelson

1. Panel Workshop #7: Multidisciplinary Management of Intraabdominal Infections – Moderator: Dr. Nesli Basgoz

2. Plenary – Infectious Diseases in Resource-Limited Settings: Lessons from the Rift Valley Fever Outbreak – Drs. Rose Muhindo and Louise Ivers

3. Endocarditis and Cardiac Device Infections – Dr. Molly L. Paras

4. The Syndemic of SUD and Infection: Updated Approaches for 2024 – Dr. Jennifer A. Johnson

5. Panel Workshop #8: Challenges in Native Valve Endocarditis (including in Persons with Substance Use Disorder) – Moderator: Dr. Molly Paras

6. Panel Workshop #9: Multidisciplinary Management of Prosthetic Valve Endocarditis (including in Persons with Substance Use Disorder) – Moderator: Dr. Molly Paras

7. Panel Workshop #10: Multidisciplinary Management of Complex Urinary Tract Infections – Moderator: Dr. Jacob Lazarus

8. Advances in Viral Hepatitis: HBV and HCV – Dr. Arthur Y. Kim

1. Cellular and Immune-Based Therapies for Cancer: What the ID Clinician Needs to Know in 2024 – Dr. Michael K. Mansour

2. Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy – Dr. Camille Nelson Kotton

3. Infections in Hematologic Malignancies and Stem Cell Transplantation – Dr. Sarah Hammond

4. Flummoxing Cases in Fungal Infections – Drs. Michael K. Mansour and Sarah Turbett

5. Clinical Manifestations of COVID, including Long COVID and COVID19 Treatment and Vaccines – Drs. Arthur Y. Kim and Rajesh T. Gandhi

6. Navigating New Vaccines: Updates and Recommendations – Dr. Camille Nelson Kotton

7. Pre- and Post-Exposure Prophylaxis for HIV and STIs – Dr. Kevin L. Ard

8. What’s New in the Care of People with HIV in 2024 – Dr. Rajesh T. Gandhi

9. Understanding and Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections – Dr. Nesli Basgoz

Notify of
Inline Feedbacks
View all comments
error: Content is protected !!